Industry Partner Programme

TACT understands the importance of working closely with industry organisations and the Industry Partner Programme (IPP) has been developed in recognition of the benefits of successful collaboration for both TACT and its partners. The annual cost of participation in the IPP is EUR10,000 and these funds are used to support TACT’s core activities, particularly the semi-annual Meetings.

Industry Partners are invited to participate in open meetings of the TACT Committees, Working Groups and General Assembly and have the opportunity to interact with global leaders in thoracic oncology to discuss and exchange information on a wide range of topics such as

  • Clinical development strategy for individual molecules, novel combinations or portfolios
  • The interface between new molecules and translational research
  • Expert clinician researcher insights into portfolio gaps and strategy; and
  • Harmonisation of processes and decision-making in the design and conduct of large scale global clinical trials


Enquire about the Industry Partner Programme